PT Kalbe Farma Tbk.
KLBF
Rank in Stocks
#6024
PT Kalbe Farma Tbk., an Indonesian pharmaceutical leader, along with its... PT Kalbe Farma Tbk., an Indonesian pharmaceutical leader, along with its subsidiaries, focuses on the development, manufacturing, and commercialization of pharmaceutical products across Indonesia. Its operations are structured into four primary divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution & Logistics. The company's diverse portfolio encompasses generic, branded, and licensed medications, including well-known names like Brainact, Cefspan, and Mycoral, which are supplied to hospitals, pharmacies, and various drugstores. Beyond prescription drugs, it offers non-prescription medicines, a range of energy and ready-to-drink beverages, dietary supplements, and other preventive health solutions. Kalbe Farma also produces specialized nutritional products tailored for all demographics, from infants to seniors, including expectant mothers and individuals with specific medical dietary needs. The firm extends contract services to other pharmaceutical companies, covering clinical study management, bioavailability/bioequivalence assessments, and analytical testing. Additionally, it provides animal health products and operates its own healthcare facilities, the Mitrasana Clinics. Its broad scope of activities further includes health screening, acting as an agent for biotechnology products, and the distribution of consumer items, medical devices, and cosmetics. The company also trades in medical and laboratory equipment and supplies, raw materials for pharmaceuticals, and consumables for hemodialysis therapy, in addition to offering advertising services. Founded in 1966, PT Kalbe Farma Tbk. is headquartered in Jakarta, Indonesia.
Share Price
$0.04249975
Last synced: 2026-11-16
Market Cap
$1.92B
Change (1 day)
1.99%
Change (1 year)
-41.90%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PT Kalbe Farma Tbk. (KLBF)
Category
Healthcare
Operating Margin for PT Kalbe Farma Tbk. (KLBF)
Operating Margin as of November 2026 TTM: 12.25%
According to PT Kalbe Farma Tbk.'s latest financial reports, its current operating margin (TTM) is 12.25%. At the end of 2025 the company had an operating margin of 12.87%.
Operating Margin history for PT Kalbe Farma Tbk. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 12.25% | -4.82% |
| 2025 | 12.87% | 3.21% |
| 2024 | 12.47% | 4.61% |
| 2023 | 11.92% | -23.25% |
| 2022 | 15.53% | -1.96% |
| 2021 | 15.84% | 0.64% |
| 2020 | 15.74% | 4.24% |
| 2019 | 15.10% | -3.33% |
| 2018 | 15.62% | -2.56% |
| 2017 | 16.03% | -0.12% |
| 2016 | 16.05% | 6.08% |
| 2015 | 15.13% | -7.01% |
| 2014 | 16.27% | 0.87% |
| 2013 | 16.13% | -2.06% |
| 2012 | 16.47% | -8.70% |
| 2011 | 18.04% | 3.03% |
| 2010 | 17.51% | 1.63% |
| 2009 | 17.23% | 18.75% |
| 2008 | 14.51% | -9.99% |
| 2007 | 16.12% | -8.62% |
| 2006 | 17.64% | -2.33% |
| 2005 | 18.06% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 46.07% | -96.24% |
US
|
|
| 25.17% | -97.95% |
US
|
|
| 35.21% | -97.13% |
US
|
|
| 31.92% | -97.39% |
CH
|
|
| 13.64% | -98.89% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PT Kalbe Farma Tbk.'s operating margin
What is PT Kalbe Farma Tbk.'s operating margin?
PT Kalbe Farma Tbk.'s operating margin is 12.25%, as of Nov 2026.
What was PT Kalbe Farma Tbk.'s operating margin in 2025?
In 2025, PT Kalbe Farma Tbk.'s operating margin was 12.87%, compared with 12.47% in 2024.
How has PT Kalbe Farma Tbk.'s operating margin changed since 2020?
From 2020 to 2025, PT Kalbe Farma Tbk.'s operating margin was highest in 2021 (15.84%) and lowest in 2023 (11.92%).
How does PT Kalbe Farma Tbk.'s operating margin compare with similar companies?
PT Kalbe Farma Tbk.'s operating margin (12.25%) is lower than that of all 5 similar companies listed above. The highest among them is Eli Lilly and Company, with 46.07%.